Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $768.55 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $191.29 | 3 | $0 (2023) |
| Johnson & Johnson Vision Care, Inc. | $109.47 | 2 | $0 (2019) |
| Sight Sciences, Inc. | $85.96 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $83.23 | 6 | $0 (2022) |
| Carl Zeiss Meditec, Inc. | $53.31 | 1 | $0 (2018) |
| Alcon Laboratories Inc | $46.04 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $44.46 | 3 | $0 (2023) |
| Shire North American Group Inc | $44.08 | 3 | $0 (2019) |
| CooperVision Inc. | $39.95 | 2 | $0 (2022) |
| Oyster Point Pharma, Inc. | $16.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.77 | 1 | Oyster Point Pharma, Inc. ($16.77) |
| 2023 | $117.04 | 2 | Alcon Vision LLC ($99.83) |
| 2022 | $80.00 | 5 | CooperVision Inc. ($39.95) |
| 2021 | $44.38 | 3 | Novartis Pharmaceuticals Corporation ($44.38) |
| 2020 | $103.55 | 3 | Alcon Vision LLC ($78.83) |
| 2019 | $194.22 | 9 | Sight Sciences, Inc. ($85.96) |
| 2018 | $193.95 | 3 | Johnson & Johnson Vision Care, Inc. ($94.60) |
| 2017 | $18.64 | 1 | Shire North American Group Inc ($18.64) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Dry eyes | ||||||
| 12/05/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Ophthalmology | ||||||
| 10/25/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $99.83 | General |
| Category: Ophthalmology | ||||||
| 10/03/2022 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Devices | ||||||
| 05/03/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/08/2022 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Devices | ||||||
| 04/05/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Glaucoma | ||||||
| 02/22/2022 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/09/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/29/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/12/2021 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/19/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $12.04 | General |
| Category: Glaucoma | ||||||
| 02/09/2020 | Alcon Vision LLC | ILUX (Device) | Food and Beverage | In-kind items and services | $78.83 | General |
| Category: Ophthalmology | ||||||
| 01/29/2020 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), CEQUA | Food and Beverage | Cash or cash equivalent | $12.68 | General |
| Category: Ophthalmology | ||||||
| 11/07/2019 | Sight Sciences, Inc. | OMNI (Device) | Food and Beverage | In-kind items and services | $85.96 | General |
| Category: Ophthalmology | ||||||
| 11/06/2019 | Eyevance Pharmaceuticals LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Ophthalmology | ||||||
| 10/25/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/10/2019 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Ophthalmology | ||||||
| 06/04/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: OPTHALMICS | ||||||
| 05/08/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: OPTHALMICS | ||||||
| 04/30/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/16/2019 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Soft Contact Lenses | ||||||
| 10/24/2018 | Alcon Laboratories Inc | ACTIVEFOCUS (Device) | Food and Beverage | In-kind items and services | $46.04 | General |
| Category: Ophthalmology | ||||||
| 05/22/2018 | Johnson & Johnson Vision Care, Inc. | Acuvue (Device) | Food and Beverage | In-kind items and services | $94.60 | General |
| Category: Soft Contact Lenses | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 141 | 165 | $17,152 | $11,760 |
| 2022 | 6 | 121 | 136 | $14,745 | $10,217 |
| 2021 | 6 | 125 | 135 | $15,617 | $10,803 |
| 2020 | 2 | 37 | 40 | $5,403 | $3,524 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 53 | 58 | $9,125 | $6,081 | 66.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 28 | 31 | $3,488 | $2,423 | 69.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $2,107 | $1,569 | 74.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 15 | $1,187 | $834.72 | 70.3% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 16 | $746.72 | $529.84 | 71.0% |
| 92145 | Measurement of corneal pressure | Office | 2023 | 17 | 31 | $497.67 | $322.87 | 64.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 35 | 36 | $5,744 | $4,111 | 71.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 29 | 36 | $4,070 | $2,733 | 67.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 15 | 15 | $2,823 | $1,898 | 67.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 12 | 13 | $1,045 | $756.46 | 72.4% |
| 92250 | Photography of the retina | Office | 2022 | 16 | 16 | $742.07 | $512.22 | 69.0% |
| 92145 | Measurement of corneal pressure | Office | 2022 | 14 | 20 | $320.48 | $205.75 | 64.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 41 | 44 | $6,931 | $4,957 | 71.5% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 19 | 19 | $3,574 | $2,397 | 67.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 23 | 28 | $3,174 | $2,330 | 73.4% |
| 92250 | Photography of the retina | Office | 2021 | 14 | 14 | $1,008 | $498.20 | 49.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 14 | 14 | $656.46 | $440.69 | 67.1% |
| 92145 | Corneal hysteresis determination | Office | 2021 | 14 | 16 | $273.12 | $179.15 | 65.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 20 | 21 | $3,308 | $2,253 | 68.1% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 17 | 19 | $2,095 | $1,272 | 60.7% |
About Dr. Madelyne Latorre, O.D
Dr. Madelyne Latorre, O.D is a Optometrist healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225444078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Madelyne Latorre, O.D has received a total of $768.55 in payments from pharmaceutical and medical device companies, with $16.77 received in 2024. These payments were reported across 27 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($768.55).
As a Medicare-enrolled provider, Latorre has provided services to 424 Medicare beneficiaries, totaling 476 services with total Medicare billing of $36,305. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Piscataway, NJ
- Active Since 07/01/2014
- Last Updated 07/01/2014
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225444078
Products in Payments
- XIIDRA (Drug) $127.31
- Acuvue (Device) $109.47
- Clareon (Device) $99.83
- OMNI (Device) $85.96
- ILUX (Device) $78.83
- CIRRUS HD-OCT (Device) $53.31
- ACTIVEFOCUS (Device) $46.04
- Clariti Contact Lens (Device) $39.95
- BROMSITE (Drug) $27.25
- Cequa (Drug) $17.21
- TYRVAYA (Drug) $16.77
- Flarex (Drug) $16.25
- ACTHAR (Biological) $14.22
- rhopressa (Drug) $12.63
- rocklatan (Drug) $12.04
- LOTEMAX (Drug) $11.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.